KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
19.39
-0.56 (-2.81%)
At close: Apr 10, 2026, 4:00 PM EDT
19.22
-0.17 (-0.88%)
After-hours: Apr 10, 2026, 4:30 PM EDT
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $993.2 million as of April 10, 2026. Its market cap has increased by 65.51% in one year.
Market Cap
993.20M
Enterprise Value
977.20M
1-Year Change
65.51%
Ranking
Category
Stock Price
$19.39
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $993.20M, an increase of 668.14%. That is a compound annual growth rate of 20.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 993.20M | 21.67% |
| Dec 31, 2025 | 816.30M | 95.01% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
| Apr 9, 2015 | 129.30M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UroGen Pharma | 1.05B |
| Septerna | 1.04B |
| ORIC Pharmaceuticals | 1.02B |
| Inventiva | 1.01B |
| Xeris Biopharma Holdings | 1.01B |
| Phathom Pharmaceuticals | 1.00B |
| GH Research | 975.10M |
| uniQure | 961.70M |